Encuentra aquí algunas publicaciones, investigaciones y documentos de diferentes autores e instituciones relacionados con el Coronavirus Covid-19
2021
Noviembre
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario
COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period
Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective
Covid 19 vaccination: Latest guidelines on blood donor deferral in India
Coping with COVID-19 pandemic in blood transfusion services in West Africa: the need to restrategize
Blood donor deferral periods after COVID-19 vaccination
Blood DonationduringCOVID-19 Vaccinationdrive - The Need for Concern
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation
“Because Every Drop Counts”: Blood donation during the COVID-19 Pandemic
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario
COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period
Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective
Covid 19 vaccination: Latest guidelines on blood donor deferral in India
Coping with COVID-19 pandemic in blood transfusion services in West Africa: the need to restrategize
Blood donor deferral periods after COVID-19 vaccination
Blood DonationduringCOVID-19 Vaccinationdrive - The Need for Concern
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation
“Because Every Drop Counts”: Blood donation during the COVID-19 Pandemic
2020
Julio
Junio
Mayo
Convalescent plasma transfusion for the treatment of COVID19: Systematic review
Convalescent plasma transfusion for the treatment of COVID19: Systematic review
The ABO blood group locus and a chromosome 3 gene cluster associate with SARSCoV- 2 respiratory failure in an Italian-Spanish genome-wide association analysis
Convalescent plasma transfusion for the treatment of COVID19: Systematic review
The ABO blood group locus and a chromosome 3 gene cluster associate with SARSCoV- 2 respiratory failure in an Italian-Spanish genome-wide association analysis
Abril
Acute leukemia in the time of COVID-19
Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV
Perspective. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
SOBRE LA SUCEPTIBILIDAD A INFECTARSE POR SARS-CoV-2 Y EL GRUPO SANGUÍNEO ABO. Por: Eduardo Muñiz-Diaz
COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals
COVID-19 and Blood Safety: Help with a Dilemma
COVID-19 convalescent plasma transfusion
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
GUIDELINES FOR SUBMITTING SPECIMENS TO CDC FOR LABORATORY TESTING FOR SARS-CoV-2
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients
Positive RT-PCR Test Results in Patients Recovered From COVID-19
Lineamiento técnico para el avance de estudios clínicos relacionados con el uso terapéutico de plasma proveniente de donantes convalecientes para Coronavirus SARS-CoV-2, responsable de ocasionar la enfermedad por Coronavirus (COVID-19) - INS Colombia
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China
CONVALESCENT PLASMA THERAPY FOR COVID-19: STATE OF THE ART.
Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Diagnostic Testing for the Novel Coronavirus
Consistent Detection of 2019 Novel Coronavirus in Saliva
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma
How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?
Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV
Perspective. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
SOBRE LA SUCEPTIBILIDAD A INFECTARSE POR SARS-CoV-2 Y EL GRUPO SANGUÍNEO ABO. Por: Eduardo Muñiz-Diaz
COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals
COVID-19 and Blood Safety: Help with a Dilemma
COVID-19 convalescent plasma transfusion
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
GUIDELINES FOR SUBMITTING SPECIMENS TO CDC FOR LABORATORY TESTING FOR SARS-CoV-2
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients
Positive RT-PCR Test Results in Patients Recovered From COVID-19
Lineamiento técnico para el avance de estudios clínicos relacionados con el uso terapéutico de plasma proveniente de donantes convalecientes para Coronavirus SARS-CoV-2, responsable de ocasionar la enfermedad por Coronavirus (COVID-19) - INS Colombia
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China
CONVALESCENT PLASMA THERAPY FOR COVID-19: STATE OF THE ART.
Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Diagnostic Testing for the Novel Coronavirus
Consistent Detection of 2019 Novel Coronavirus in Saliva
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma
How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?
Marzo
Clinical management of severe acute respiratory infection
(SARI) when COVID-19 disease is suspected
Lineamiento técnico para Bancos de Sangre y Servicios de Transfusión,relacionados con el coronavirus SARSCoV-2, responsable de ocasionar la enfermedad por Coronavirus (COVID-19)
Virological assessment of hospitalized cases of coronavirus disease 2019
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
LINEAMIENTOS PARA EL MANEJO DEL AISLAMIENTO DOMICILIARIO, FRENTE A LA INTRODUCCIÓN DEL SARS-CoV-2 (COVID-19) A COLOMBIA.
Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)
Is novel coronavirus disease (COVID‐19) transmitted through conjunctiva?
Atención en el domicilio de pacientes presuntamente infectados por el nuevo coronavirus (nCoV) que tengan síntomas leves y gestión de los contactos
MANUAL DE BIOSEGURIDAD PARA PRESTADORES DE SERVICIOS DE SALUD QUE BRINDEN ATENCIÓN EN SALUD ANTE LA EVENTUAL INTRODUCCIÓN DEL NUEVO CORONAVIRUS (NCOV-2019) A COLOMBIA.
Webinar: Can we secure the blood supply in COVID-19? The Hong Kong experience
Coronavirus restrictions could lead to U.S. blood shortage in two weeks: blood banks group
Donación de Sangre y SARS-CoV-2
Recommendations for Providing a Safe Environment for Blood Donation During the COVID19 Epidemic
AABB’s Resources for: FDA’s Updated Information for Blood Establishments Regarding the Novel Coronavirus (COVID-19) Outbreak. March 2020
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. Guidance for Industry, Investigators, and Institutional Review Boards
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
Recomendaciones para el abordaje terapéutico de COVID19 - Ministerio de Salud Argentina
Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19)
RECOMENDACIONES POR EL NUEVO CORONAVIRUS SARS-COV2 EN PACIENTES CON TRASPLANTE DE CÉLULAS PROGENITORAS HEMATOPOYÉTICAS Y ONCOHEMATOLÓGICOS
Conferencia Virtual: Update on the COVID-19 Coronavirus Outbreak: Blood Collection and Safety Implications
AIDE-MEMOIRE COVID-19 For Members, Blood Banks, Transfusion Services and Hospitals VERSIÓN INGLÉS
AIDE-MEMOIRE COVID-19 For Members, Blood Banks, Transfusion Services and Hospitals VERSIÓN ESPAÑOL
Investigational COVID-19 Convalescent Plasma - Emergency INDs (Investigation New Drugs)
AGOTAMIENTO FUNCIONAL DE LINFOCITOS ANTIVIRALES EN PACIENTES CON COVID-19
Hipótesis para la posible patogénesis de la infección por CoV-2 del SARS: una revisión de los cambios inmunes en pacientes con neumonía viral
ASPECTOS HEMATOLÓGICOS DE LA PANDEMIA por SARS-CoV-2
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
RECOMENDACIONES PARA LA OBTENCIÓN DE PLASMA DE DONANTES CONVALECIENTES DE COVID-19
Transfusión y CORONAVIRUS. Infección por nuevo coronavirus (COVID-19)
LA PANDEMIA DEL COVID-19: EXPERIENCIA DE LOS CLÍNICOS EN ESPAÑA - WEBINAR
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The feasibility of convalescent plasma therapy in severe COVID19 patients: a pilot study
Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis
Convalescent plasma as a potential therapy for COVID-19
REFERENCIA: Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks
Convalescent Plasma toTreat COVID-19 Possibilities and Challenges
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis
Lineamiento técnico para Bancos de Sangre y Servicios de Transfusión,relacionados con el coronavirus SARSCoV-2, responsable de ocasionar la enfermedad por Coronavirus (COVID-19)
Virological assessment of hospitalized cases of coronavirus disease 2019
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
LINEAMIENTOS PARA EL MANEJO DEL AISLAMIENTO DOMICILIARIO, FRENTE A LA INTRODUCCIÓN DEL SARS-CoV-2 (COVID-19) A COLOMBIA.
Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)
Is novel coronavirus disease (COVID‐19) transmitted through conjunctiva?
Atención en el domicilio de pacientes presuntamente infectados por el nuevo coronavirus (nCoV) que tengan síntomas leves y gestión de los contactos
MANUAL DE BIOSEGURIDAD PARA PRESTADORES DE SERVICIOS DE SALUD QUE BRINDEN ATENCIÓN EN SALUD ANTE LA EVENTUAL INTRODUCCIÓN DEL NUEVO CORONAVIRUS (NCOV-2019) A COLOMBIA.
Webinar: Can we secure the blood supply in COVID-19? The Hong Kong experience
Coronavirus restrictions could lead to U.S. blood shortage in two weeks: blood banks group
Donación de Sangre y SARS-CoV-2
Recommendations for Providing a Safe Environment for Blood Donation During the COVID19 Epidemic
AABB’s Resources for: FDA’s Updated Information for Blood Establishments Regarding the Novel Coronavirus (COVID-19) Outbreak. March 2020
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. Guidance for Industry, Investigators, and Institutional Review Boards
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
Recomendaciones para el abordaje terapéutico de COVID19 - Ministerio de Salud Argentina
Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19)
RECOMENDACIONES POR EL NUEVO CORONAVIRUS SARS-COV2 EN PACIENTES CON TRASPLANTE DE CÉLULAS PROGENITORAS HEMATOPOYÉTICAS Y ONCOHEMATOLÓGICOS
Conferencia Virtual: Update on the COVID-19 Coronavirus Outbreak: Blood Collection and Safety Implications
AIDE-MEMOIRE COVID-19 For Members, Blood Banks, Transfusion Services and Hospitals VERSIÓN INGLÉS
AIDE-MEMOIRE COVID-19 For Members, Blood Banks, Transfusion Services and Hospitals VERSIÓN ESPAÑOL
Investigational COVID-19 Convalescent Plasma - Emergency INDs (Investigation New Drugs)
AGOTAMIENTO FUNCIONAL DE LINFOCITOS ANTIVIRALES EN PACIENTES CON COVID-19
Hipótesis para la posible patogénesis de la infección por CoV-2 del SARS: una revisión de los cambios inmunes en pacientes con neumonía viral
ASPECTOS HEMATOLÓGICOS DE LA PANDEMIA por SARS-CoV-2
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
RECOMENDACIONES PARA LA OBTENCIÓN DE PLASMA DE DONANTES CONVALECIENTES DE COVID-19
Transfusión y CORONAVIRUS. Infección por nuevo coronavirus (COVID-19)
LA PANDEMIA DEL COVID-19: EXPERIENCIA DE LOS CLÍNICOS EN ESPAÑA - WEBINAR
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The feasibility of convalescent plasma therapy in severe COVID19 patients: a pilot study
Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis
Convalescent plasma as a potential therapy for COVID-19
REFERENCIA: Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks
Convalescent Plasma toTreat COVID-19 Possibilities and Challenges
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis
Febrero
Coronavirus Disease 2019: Coronaviruses and Blood Safety
BIOSEGURIDAD: Directrices provisionales de bioseguridad de laboratorio para el manejo y transporte de muestras asociadas al nuevo coronavirus 2019 (2019-nCoV)
DETECCIÓN Y DIAGNÓSTICO: Directrices de Laboratorio para la Detección y Diagnóstico de la Infección con el Nuevo Coronavirus 2019 (2019-nCoV)
ALISTAMIENTO EN HOSPITALES: Lecturas recomendadas para la verificación de alistamiento para la respuesta al COVID-19 en Hospitales
ALISTAMIENTO EN HOSPITALES: Lista de verificación de alistamiento para la respuesta al 2019-nCoV en Hospitales
PREVENCIÓN Y CONTROL DE INFECCIONES: Presentación: prevención y control de infecciones y nuevo coronavirus (COVID-19): precauciones estándares y uso de equipos de protección personal
USO DE EQUIPOS DE PROTECCIÓN PERSONAL - EPP: Requerimientos para uso de equipos de protección personal (EPP) para el nuevo coronavirus (2019-nCoV) en establecimientos de salud
SERVICIOS DE SANGRE: Recomendaciones preliminares para los servicios de sangre frente al potencial impacto de la diseminación de la infección de Coronavirus (COVID-19,) en la disponibilidad y seguridad de la sangre y componentes sanguíneos
SERVICIOS DE SANGRE: Enfermedad por el Coronavirus (COVID-19)
LINEAMIENTOS A IMPLEMENTAR DE PREVENCIÓN PARA PREPARACIÓN, RESPUESTA Y ATENCIÓN DE CASOS DE ENFERMEDAD POR COVID-19 EN COLOMBIA
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China
Potential interventions for novel coronavirus in China: A systematic review
BIOSEGURIDAD: Directrices provisionales de bioseguridad de laboratorio para el manejo y transporte de muestras asociadas al nuevo coronavirus 2019 (2019-nCoV)
DETECCIÓN Y DIAGNÓSTICO: Directrices de Laboratorio para la Detección y Diagnóstico de la Infección con el Nuevo Coronavirus 2019 (2019-nCoV)
ALISTAMIENTO EN HOSPITALES: Lecturas recomendadas para la verificación de alistamiento para la respuesta al COVID-19 en Hospitales
ALISTAMIENTO EN HOSPITALES: Lista de verificación de alistamiento para la respuesta al 2019-nCoV en Hospitales
PREVENCIÓN Y CONTROL DE INFECCIONES: Presentación: prevención y control de infecciones y nuevo coronavirus (COVID-19): precauciones estándares y uso de equipos de protección personal
USO DE EQUIPOS DE PROTECCIÓN PERSONAL - EPP: Requerimientos para uso de equipos de protección personal (EPP) para el nuevo coronavirus (2019-nCoV) en establecimientos de salud
SERVICIOS DE SANGRE: Recomendaciones preliminares para los servicios de sangre frente al potencial impacto de la diseminación de la infección de Coronavirus (COVID-19,) en la disponibilidad y seguridad de la sangre y componentes sanguíneos
SERVICIOS DE SANGRE: Enfermedad por el Coronavirus (COVID-19)
LINEAMIENTOS A IMPLEMENTAR DE PREVENCIÓN PARA PREPARACIÓN, RESPUESTA Y ATENCIÓN DE CASOS DE ENFERMEDAD POR COVID-19 EN COLOMBIA
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China
Potential interventions for novel coronavirus in China: A systematic review
Enero
OPS: Actualización Epidemiológica Nuevo coronavirus (2019- nCoV)
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China
Anexo 1. Lineamiento técnico para selección de donantes en Colombia – Criterios relacionados con 2019 – nCoV
Criterios técnicos para la selección de donantes relacionados con 2019–nCoV (Coronavirus de Wuhan) en Paraguay
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China
Anexo 1. Lineamiento técnico para selección de donantes en Colombia – Criterios relacionados con 2019 – nCoV
Criterios técnicos para la selección de donantes relacionados con 2019–nCoV (Coronavirus de Wuhan) en Paraguay
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia